Sareum Hldgs Plc
Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. The company was founded in 2003 and is based in Cambridge, the United Kingdom. Show More...
-
Website https://www.sareum.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 14.25 GBX
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-06 2011-06 2012-06 2013-06 2014-06 2015-06 2016-06 2017-06 2018-06 2019-06 TTM Earnings Per Share GBP Dividends GBP Payout Ratio % * Shares Mil 1.086 1.349 1.452 1.494 1.693 1.942 2.525 2.741 2.706 2.827 2.97 Book Value Per Share * GBP Free Cash Flow Per Share * GBP Return on Assets % -114.03 -71.31 -82.55 -96.08 -66.13 -67.51 -53.84 17.94 -68.08 -95.02 -81.49 Financial Leverage (Average) 1.19 1.11 1.26 1.18 1.04 1.04 1.05 1.07 1.11 1.13 1.13 Return on Equity % -134.04 -81.2 -95.93 -117.27 -70.58 -70.02 -56.25 19.02 -73.88 -106.53 -89.3 Return on Invested Capital % -134.67 -82.49 -96.57 -117.92 -70.97 -70.17 -56.45 18.91 -74.04 -106.79 -89.61 Interest Coverage Current Ratio 6.37 10.02 4.91 6.49 16.36 25.47 14.93 15.65 9.63 8.23 8.46 Quick Ratio 6.13 9.67 4.16 5.28 13.69 21.95 12.58 15.23 8.13 6.57 6.52 Debt/Equity